MetaCap

Milestone Pharmaceuticals (MIST) vs Quantum Cyber N.V. (QUCY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Quantum Cyber N.V. (QUCY) has outperformed Milestone Pharmaceuticals (MIST) over the past year, losing 48.7% versus a loss of 84.5%. Over five years, MIST leads with a -93.8% price change compared with -94.8% for QUCY. Milestone Pharmaceuticals is the larger company by market cap ($46.2 million vs $44.7 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MIST-84.54%QUCY-48.75%
+273%+86%-102%
Nov 21, 20251 yearNov 20, 2026
MIST-93.88%QUCY-94.78%
+197%+43%-112%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MIST versus QUCY key metrics
MetricMISTQUCY
Share price$0.3711$0.512
Market cap$46.20M$44.67M
1-day change-7.06%-7.25%
YTD return-81.63%-54.29%
1-year return-84.54%-48.75%
5-year return-93.85%-94.80%
EPS (TTM)$-0.74$-2.27
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$537.08K
Revenue growth (YoY)—-39.92%
Net income (latest FY)$-63.06M$-16.21M
Gross margin—72.58%
Operating margin—-3004.97%
Net margin—-3018.31%
52-week high$3.06$4.93
52-week low$0.362$0.30
Distance from 52-week high-87.87%-89.61%
Analyst consensusnonenone
Avg. price target upside+1479.09%+1657.81%
Average volume1.53M528.02K
Shares outstanding124.50M87.24M
Employees3810
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • QUCY has outperformed MIST by 35.8 percentage points over the past year.

About Milestone Pharmaceuticals

MIST stock →

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults.

Health Care · Biotechnology: Pharmaceutical Preparations · 38 employees

About Quantum Cyber N.V.

QUCY stock →

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.

Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees

MIST vs QUCY FAQ

Which is bigger, Milestone Pharmaceuticals or Quantum Cyber N.V.?

Milestone Pharmaceuticals (MIST) is larger, with a market capitalization of $46.20M compared with $44.67M for Quantum Cyber N.V. (QUCY).

Which stock has performed better over the past year, MIST or QUCY?

QUCY returned -48.75% over the past 12 months, compared with -84.54% for MIST (price return, excluding dividends). Past performance does not predict future results.

Are Milestone Pharmaceuticals and Quantum Cyber N.V. in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons